Literature DB >> 16142677

Prevalence of Candida dubliniensis fungemia at a large teaching hospital.

Mary Ann Jabra-Rizk1, Jennifer K Johnson, Graeme Forrest, Kristina Mankes, Timothy F Meiller, Richard A Venezia.   

Abstract

Six cases of Candida dubliniensis fungemia were identified during an 8-month period in hospitalized patients with various conditions, including human immunodeficiency virus infection. Peptide nucleic acid fluorescent in situ hybridization analysis was used as a rapid and reliable test for differentiating C. dubliniensis from Candida albicans, making it feasible to determine the prevalence of C. dubliniensis fungemia.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16142677     DOI： 10.1086/432943

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  20 in total

1.  8th ASM conference on Candida and candidiasis: molecular tools provide insights into host-pathogen interactions.

Authors:  Gary P Moran; Mary Ann Jabra-Rizk
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

2.  Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors:  Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

3.  Rapid and accurate identification of Candida albicans isolates by use of PNA FISHFlow.

Authors:  Jan Trnovsky; William Merz; Phyllis Della-Latta; Fann Wu; Maiken Cavling Arendrup; Henrik Stender
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

4.  Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.

Authors:  Renátó Kovács; Qasem Saleh; Aliz Bozó; Zoltán Tóth; Rudolf Gesztelyi; Tamás Kardos; Gábor Kardos; István Takacs; László Majoros
Journal:  Mycopathologia       Date:  2017-07-11       Impact factor: 2.574

5.  First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.

Authors:  Yi P Ge; Guo X He; Tong Lin; Gui X Lu; Yong N Shen; Wei D Liu
Journal:  Mycopathologia       Date:  2011-07-17       Impact factor: 2.574

6.  Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.

Authors:  M A Jabra-Rizk; T F Meiller; C E James; M E Shirtliff
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Importance of α- and β/α-linked mannooligosaccharides in antibody response against C. dubliniensis.

Authors:  Izabela Medovarská; Slavomír Bystrický; Zuzana Kossaczká; Eva Machová
Journal:  Glycoconj J       Date:  2010-11-26       Impact factor: 2.916

8.  Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Authors:  G N Forrest; K Mankes; M A Jabra-Rizk; E Weekes; J K Johnson; D P Lincalis; R A Venezia
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 9.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

10.  Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.

Authors:  Sebastian J van Hal; Damien Stark; John Harkness; Deborah Marriott
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.